Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)

NCT ID: NCT05865314

Last Updated: 2025-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

164 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-01

Study Completion Date

2026-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Due to medical advances and quality of care, mortality in adult intensive care units (ICUs) has decreased significantly in recent years, leading to a significant increase in the number of patients with high rehabilitation needs on discharge from the ICU.

A specific management by a multidisciplinary team has been set up since 2017 at the Geneva-ICU for long-stay patients (hospitalised ≥ 7 days).

This study aim to assess whether an optimization of the nutritional therapy coupled with an early mobility during and after the ICU stay allows an improvement in the muscle function at hospital discharge compared to patients receiving the standard care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Due to medical advances and quality of care, mortality in adult intensive care units (ICUs) has decreased significantly in recent years, leading to a significant increase in the number of patients with high rehabilitation needs on discharge from the ICU. Indeed, these patients are at high risk of complications related to their ICU stay (cognitive impairment, ICU acquired weakness, diaphragm dysfunction, ICU polyneuropathy, post-traumatic stress, malnutrition, etc.). Despite prolonged periods of rehabilitation, there is a significant decrease in functional status and quality of life compared to the previous status of these patient.

A specific management by a multidisciplinary team has been set up since 2017 at the Geneva-ICU for long-stay patients (hospitalised ≥ 7 days) including special attention to weaning from ventilation, nutrition, mobilisation, anxiety, pain, skin condition etc.

The culture of nutritional therapy and early mobilisation is already well established at the Geneva-ICU. However, a comprehensive approach to nutrition and mobilisation during and after the ICU stay could be optimised.

The objective of the study is to determine whether optimization of nutritional therapy combined with early mobilization for patients with long ICU stay will improve muscle function at discharge compared with patients receiving standard care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness ICU Acquired Weakness Malnutrition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional group

Group Type EXPERIMENTAL

Optimisation of nutrition therapy coupled with early mobilisation

Intervention Type OTHER

Optimisation of nutrition therapy coupled with early mobilisation with:

* Optimisation of nutrition therapy during ICU stay
* Optimisation of physiotherapy during ICU stay
* Better communication and closer collaboration between physiotherapy and nutrition teams.
* Optimisation of continuity of the care.

Control group

Group Type ACTIVE_COMPARATOR

Standard care

Intervention Type OTHER

Patients will receive nutritional therapy and mobilisation according to local standard procedures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Optimisation of nutrition therapy coupled with early mobilisation

Optimisation of nutrition therapy coupled with early mobilisation with:

* Optimisation of nutrition therapy during ICU stay
* Optimisation of physiotherapy during ICU stay
* Better communication and closer collaboration between physiotherapy and nutrition teams.
* Optimisation of continuity of the care.

Intervention Type OTHER

Standard care

Patients will receive nutritional therapy and mobilisation according to local standard procedures.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Any patient admitted to the adult ICU :

* ≥18 years old
* On mechanical ventilation with an expected length of stay ≥ 7 days
* Requiring artificial nutrition (enteral and/or parenteral nutrition)

Exclusion Criteria

Therapeutic withdrawal Pregnant or breastfeeding patients

Neurological disorders with motor deficits:

* New or pre-existing neuromuscular or nervous system disease
* Spinal cord injury Severe polytrauma of the lower limbs (amputation etc.) Non-independent ambulation (including walking aids) before ICU admission

For organizational reasons not allowing follow-up :

* Transfer to another ICU
* Patient living abroad from Switzerland
* Patient living in nursing homes preceding to ICU admission
* Incarcerated patients
* Intellectual/cognitive disabilities or language barrier, limiting ability to follow the instructions
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HEIDEGGER CP

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

HEIDEGGER CP

Deputy head physician, Head of the Intensive Care Polyvalent Unit, Division of Intensive Care

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Claudia Heidegger, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Geneva

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service of Intensive Care, Geneva University Hospital,

Geneva, Canton of Geneva, Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Claudia Heidegger, MD

Role: CONTACT

+ 41 22 37 27 440

Aude de Watteville, Bsc

Role: CONTACT

+ 41 79 55 33 998

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Claudia Heidegger, MD

Role: primary

Aude De Watteville, Bsc

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NutriPhyT2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.